Close Menu

NEW YORK – Proteomic diagnostics firm SomaLogic is pushing its aptamer-based technology into the clinic with the recent launch of the first tests on its SomaScan platform.

The Boulder, Colorado-based company announced this month that it would begin offering seven proteomic tests at several Colorado doctors' practices. The releases mark SomaLogic's first move into clinical testing after several years of development work.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.